Follow The Filings

GH Guardant Health Inc.

Health Care, filed as GUARDANT HEALTH INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q3, sold by 3

  • 5 Owners
  • Max 0.6%
  • $181M
  • 1 new 1 add 3 reduce

In 2026 Q3, 1 manager opened a position, 1 added, and 3 trimmed.

Who owns this now

Largest portfolio weights among holders, up to 0.6% (Cathie Wood, ARK Investment Management). Not free-float ownership.

  1. Cathie Wood Add 0.62%
  2. Farallon Capital Management Reduce 0.21%
  3. Davidson Kempner Capital… New 0.21%
  4. Polen Capital Management Reduce 0.01%

Who owns GH

Sorted by value, long equity only, as of 2026 Q3.

History
Cathie Wood, ARK Investment Management 0.62%, was 0.49% Add +19.9% 607,173 $108M History
Farallon Capital Management 0.21%, was 0.22% Reduce −13.2% 279,700 $50M History
Davidson Kempner Capital Management 0.21% New 0.21% 106,902 $19M History
Ron Baron, BAMCO Inc. (Baron Capital) <0.01% Reduce −15.2% 14,000 $2.5M History
Polen Capital Management 0.01%, was 0.04% Reduce −84.7% 5,262 $939K History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GH insider trades
  • $78K bought by 1 insider
  • $91.8M sold by 10 insiders outside a trading plan
  • $81.7M sold by 7 insiders under 10b5-1 plans
  1. Terilyn J. Monroe Chief People Officer
    Planned sale
    $547K 3,842 shares at $142.41 15% of stake
    Traded Nov 18 Filed Nov 19
  2. Musa Tariq Director
    Planned sale
    $17K 116 shares at $149.56 1% of stake
    Traded Nov 16 Filed Nov 17
  3. Alex M. Azar II Director
    Planned sale
    $10K 69 shares at $149.56 6.7% of stake
    Traded Nov 16 Filed Nov 17
  4. Musa Tariq Director
    Planned sale
    $19K 116 shares at $165.88 1% of stake
    Traded Oct 16 Filed Oct 19
  5. Alex M. Azar II Director
    Planned sale
    $11K 69 shares at $159.89 7.2% of stake
    Traded Oct 14 Filed Oct 15
  6. Darya Chudova Chief Technology Officer
    Sale
    $1.4M 7,738 shares at $178.00 9.9% of stake
    Traded Sep 15 Filed Sep 17
  7. Musa Tariq Director
    Planned sale
    $20K 116 shares at $175.00 1% of stake
    Traded Sep 16 Filed Sep 17
  8. Steve E. Krognes Director
    Sale
    $1.2M 6,674 shares at $175.74 46% of stake
    Traded Sep 16 Filed Sep 17
  9. Alex M. Azar II Director
    Planned sale
    $145K 826 shares at $175.00 50% of stake
    Traded Sep 16 Filed Sep 17
  10. Kumud Kalia Chief Information Officer
    Sale
    $632K 4,000 shares at $158.05 9.1% of stake
    Traded Sep 11 Filed Sep 14
  11. AmirAli Talasaz CEO
    Sale
    $6.3M 37,500 shares at $169.16 50% of stake
    Traded Aug 21 Filed Aug 24
  12. Musa Tariq Director
    Planned sale
    $18K 116 shares at $156.45 1% of stake
    Traded Aug 17 Filed Aug 18
  13. Terilyn J. Monroe Chief People Officer
    Sale
    $7.6M 46,300 shares at $165.12 67% of stake
    Traded Aug 12 Filed Aug 13
  14. Chris Freeman Chief Commercial Officer
    Sale
    $10.8M 63,605 shares at $169.58 49% of stake
    Traded Aug 10 Filed Aug 11
  15. Medina Manuel Hidalgo Director
    Sale
    $279K 1,700 shares at $164.24 27% of stake
    Traded Aug 5 Filed Aug 6

Also filed in the last 12 months, not counted as buying or selling: 231 option exercises, 64 share withholdings for taxes, 11 other transactions, and 6 gifts.

Congress

2 members of Congress traded GH in the last three years: 2 buys and 0 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Jonathan L. Jackson D-IL-1Joint Buy $15K–$50K Sep 28 filed Oct 19
  2. Sheldon Whitehouse D-RI Buy $1K–$15K Nov 21, 2025 filed Dec 1, 2025

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
8-K 1.01,2.03,3.02,8.01,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 5.02,9.01
8-K 5.02,9.01
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $982.02M
Gross profit * — — $633.01M
Gross margin * — — 64.5%
Net income -$479.45M -$436.37M -$416.28M
Net margin * — — -42.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.35B $1.06B $1.47B
Total non-current assets * $439.32M $430.5M $547.61M
Total assets $1.79B $1.49B $2.01B
Total current liabilities $205.92M $225.58M $302.73M
Total non-current liabilities * $1.42B $1.4B $1.81B
Total equity $158.68M -$139.65M -$99.31M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$324.98M -$239.86M -$184.76M
Cash from investing $840.25M -$261.31M -$627.2M
Cash from financing $477.38M -$0.996M $671.13M
Net change in cash $991.74M -$503.93M -$140.34M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf